This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Impact Biomedicines, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations by Yu Liu in Cancer Treatment
Introduction
Yu Liu is an accomplished inventor based in Brookline, MA (US), known for his significant contributions to cancer treatment. His innovative work focuses on developing therapeutic methods that target specific proteins involved in cancer progression.
Latest Patents
Yu Liu holds a patent for BET inhibitors as a treatment for myelofibrosis. The patent outlines methods, pharmaceutical compositions, and kits designed for treating cancer in patients. The methods involve administering a BET (bromodomain and extra-terminal protein) inhibitor, or a pharmaceutically acceptable salt thereof, either alone or in combination with one or more JAK inhibitors. This innovative approach aims to provide effective medicaments for cancer treatment.
Career Highlights
Throughout his career, Yu Liu has demonstrated a commitment to advancing medical science through his research and inventions. His work has the potential to significantly impact the treatment landscape for patients suffering from myelofibrosis and other cancers.
Collaborations
Yu Liu has collaborated with notable colleagues, including Ida Aronchik and Roxxana Valeria Beltran Valencia, to further enhance the development of his innovative treatments.
Conclusion
Yu Liu's contributions to cancer treatment through his patent on BET inhibitors exemplify the importance of innovation in medical research. His work not only showcases his expertise but also holds promise for improving patient outcomes in cancer therapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile